An evaluation of the efficacy of eptinezumab in the inpatient management of status migrainosus in comparison to intravenous lignocaine in patients who have failed other therapies
Latest Information Update: 30 Nov 2021
At a glance
- Drugs Eptinezumab (Primary) ; Lidocaine
- Indications Migraine; Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- Acronyms SMITE
- 30 Nov 2021 New trial record